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Influence of biliary anastomosis on recovery from secondary
biliary cirrhosis
Jose´ Sebastia˜o dos Santos, Rafael Kemp, Murilo Ferreira de Andrade
and Luciano Neder
Objective The influence of choledochoduodenostomy and
choledochojejunostomy on the repair of hepatic lesions
secondary to biliary obstruction is not well known. The aim
of the present study was to compare the effects of
choledochoduodenostomy and choledochojejunostomy on
the recovery of these lesions in rats with biliary obstruction.
Methods Rats subjected to 4 weeks of biliary obstruction
underwent choledochoduodenostomy (n= 10) or
choledochojejunostomy (n= 10). The following variables
were measured: total bilirubin, alkaline phosphatase,
aminotransferases, and albumin. Hepatic mitochondrial
energy metabolism was evaluated by calculating the
respiratory control ratio and the oxidative phosphorylation
index. Hepatic morphometry was used to estimate the
mass of the hepatocytes, bile ducts, and fibrosis, as well as
the hepatic stellate cell count.
Results After choledochoduodenostomy and
choledochojejunostomy, there was a regression in
cholestasis and a reduction in the oxidative
phosphorylation index. However, the total bilirubin, alkaline
phosphatase, albumin, and respiratory control ratio values
improved only after choledochojejunostomy. The mass of
the liver, spleen, and fibrosis was reduced after both
choledochoduodenostomy and choledochojejunostomy,
but the number of hepatic stellate cells increased.
After choledochojejunostomy, the hepatic mass recovered
completely, and the spleen mass was significantly reduced
compared with that after choledochoduodenostomy.
After both choledochoduodenostomy and
choledochojejunostomy, enterobiliary reflux, biliary
contamination, and an exacerbation in hepatic
inflammation developed.
Conclusion Choledochojejunostomy was more effective
than choledochoduodenostomy, but both techniques
induced enterobiliary reflux and biliary contamination,
which may explain the maintenance of hepatic alterations,
especially after choledochoduodenostomy. Eur J
Gastroenterol Hepatol 24:1039–1050 c 2012 Wolters
Kluwer Health | Lippincott Williams & Wilkins.
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Introduction
In clinical practice, fibrosis and secondary biliary cirrhosis
are frequently considered to be irreversible hepatic
lesions [1]. However, clinical [2–4] and experimen-
tal [5–8] reports have shown that effective biliary
decompression can promote the reversion of anatomo-
pathological alterations in the liver.
Among the different methods used to treat extrahepatic
cholestasis, choledochoduodenostomy (CD) and chole-
dochojejunostomy (CJ) are frequently applied. In clinical
practice, the choice between these two biliary anasto-
mosis modalities for the treatment of an extrahepatic
biliary obstruction (BO) depends more on the experience
of the surgeon than on the pathogenesis of the disease
being treated [9].
The use of CD in rats with secondary biliary fibrosis leads
to the resolution of cholestasis, but without recovery of
anatomopathological lesions and portal hypertension [10].
In similar hepatic lesions, resolution of the excretory
function, regression in the liver lesions, and decreased
portal pressure levels were observed after CJ [6]. In
contrast, alterations in the motility of the excluded loop
in conventional Roux-en-Y can lead to stasis, bacterial
growth, and hepatic fibrosis [8,11,12].
Currently, it is widely believed that the therapeutic results
of a BO treatment depend more on the etiology of the
obstruction and the patency of the anastomosis than on
the technique of biliodigestive anastomosis used [13,14].
These observations, in addition to the technical simplicity,
have likely contributed to the considerable use of CD for
the treatment of chronic BO, especially when using a
video-laparoscopic approach.
Therefore, the aim of the present study was to compara-
tively evaluate the influence of CD and CJ techniques on
the recovery of metabolic and anatomopathological liver
lesions in rats with chronic BO.
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Methods
Experimental design
Male Wistar rats with an initial weight between 232 and
317 g were divided into four groups: a BO group (n= 6),
which included rats subjected to a bile duct ligation for
1 month; a CD group (n= 10) and a CJ group (n= 10),
which included rats subjected to a bile duct ligation for
1 month and treated with either CD or CJ, respectively;
and a fourth group that was subjected to a sham operation
(SO; n= 8). The CD, CJ, and SO groups were evaluated
3 months after treatment (Fig. 1).
Surgical technique
The use of laboratory animals was in accordance with the
Council for International Organizations of Medical
Sciences Ethical Code for Animal Experimentation. The
animals were anesthetized with pentobarbital (40–60
mg/kg by an intraperitoneal injection). The BO was
performed according to a technique developed by our
group involving the ligation of the biliary duct with five
knots of a Prolene suture (Prolene Suture-blue monofila-
ment 5/0, Ethicon Inc., Sa˜o Paulo, Brazil) B3mm above
the biliary–pancreatic junction. Subsequently, using the
same suture, the biliary duct was circled up toB5mm of
the lobar duct confluence, where an additional ligature
was performed again with five knots [8].
Immediately before the biliary anastomosis, 2ml blood
sample was collected by a cava vein puncture, followed by
an infusion of 6ml of a 5% glucophysiologic solution. The
following procedures were then performed: a laparotomy,
a liver biopsy, and an anastomosis between the anterior
wall of the bile duct and either the duodenum (for CD)
or the distal extremity of the jejunum (for CJ), which was
sectioned 5 cm from the duodenojejunal angle. The
continuity of the jejunum was established through end-
to-side anastomosis 15 cm from the duct-to-jejunum
anastomosis. The anastomosis was performed with a
continuous suture (Vicryl 5-0, Ethicon Inc.).
At the end of the experiment, 1 month after the BO
procedure for the BO group and 3 months after the
anastomosis procedure for the CD, CJ, and SO groups,
the animals were subjected to a laparotomy, followed by
the collection of bile, splenectomy, collection of a blood
sample from the vena cava, inspection of the anastomosis,
and removal of the liver.
Studies performed
Liver and spleen wet weight
After removal, the liver and the spleen were weighed on a
precision scale. The weight was in g/kg of corporeal weight.
Biochemical measures
The blood samples were collected to measure the total
bilirubin (TB), the direct and indirect bilirubin frac-
tions [15], and the amount of alanine aminotransferase
(ALT), aspartate aminotransferase [16], alkaline phosphatase
Fig. 1
SO group
(n = 8)
After 1 month
Choledochoduodenostomy
CD group
(n = 10)
CJ group
(n = 10)
Choledochojejunostomy
After 3 months
BO
(n = 6)
BO1
(n = 10)
BO2
(n = 10)
• Liver and spleen weight
• Blood biochemical analysis (bilirubin, alkaline phosphatase, aminotranferase, albumin)
• Hepatic tissue biochemical analysis
• Qualitative and quantitative hepatic histological analysis
After 4 months
Rats with biliary obstruction (n = 26)
Groups
Blood biochemical analysis
Liver histological analysis
After 1 month
Research design. BO, biliary obstruction; CD, choledochoduodenostomy; CJ, choledochojejunostomy; SO, sham operation.
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(ALP) [17], and albumin (ALB) [18]. All the biochemical
tests were performed using Labtest Kits (Labtest
Diagnostic Systems LTDA; Belo Horizonte, Minas
Gerais, Brazil).
Microbiological evaluation
Bile samples were collected with surgical asepsis through a
puncture of the biliary duct using a 13 4 hypodermic
needle and placed in Eppendorf tubes containing a highly
nutritious broth (brain heart infusion). After 24h of
incubation in a microbiologic stove at 351C, the samples
were seeded onto one of three selective environments:
blood, mannitol, or MacConkey agar. After 24h, a semi-
automatic identification of the samples with bacterial
growth was performed (autoScan-4/Dade Micro Scan Inc.,
Sacramento, California, USA). A standard suspension (0.5
on the McFarland scale) of the microorganisms under
investigation was inoculated in each of the wells of the
plate. After 15–24 h of incubation at 351C, an automated
colorimetric reading was taken to detect bacterial growth.
Histological evaluation of the liver
Liver fragments were fixed by immersion in Carnoy liquid
(60% glacial acetic acid) for 3 h. The liver tissue was then
transferred to a 70% alcohol solution. Hepatic paren-
chyma sections (5mm thick) were stained using hema-
toxylin and eosin and by Masson trichrome.
To identify the hepatic stellate cells (HSC), immunohis-
tochemistry was performed on sections using a mono-
clonal antidesmin antibody (IgG, Dako, Carpinteria,
California, USA; dilution 1 : 200) following the manufac-
turer’s specifications.
The morphometric analysis of the liver histology was
performed on sections stained by Masson trichromic by a
single examiner who was blinded to the slide identification
codes and the respective treatments. Histological images
were captured on an optical microscope Axiophot (Carl
Zeiss Vision GmbH, Hallbergmoos, Germany) coupled to a
digital camera (Sony Corp., Tokyo, Japan). The images were
transferred to a computer through the Frame Grabber (Carl
Zeiss Vision GmbH) image-capturing board. The images
were captured in the RGB standard format at a 648 474
resolution for analysis using the graphics software
KS400 V2.0 (Kontron Elektronik GmbH, Mu¨nchen,
Germany) [19]. Three distinct structures were identified
for analysis: hepatocytes, which were red-stained structures;
fibrosis, represented by blue-stained structures; and bile
ducts, whose staining did not allow an automatic identifica-
tion by the system. The areas in the three spectra that best
represented the histological component under evaluation
were marked.
Once the structures were identified, an automated process
was initiated to obtain the areas of the selected components.
As a result, the percentage of the selected histological
components present in the analyzed fragment was
calculated using the selected area and the total area of
the captured frame. Through a previous pilot study, we
had determined that the analysis of 30 fields at a  256
magnification yields a representative sample of each slide.
For each animal, the computer program randomly
selected 30 fields per slide for morphometric analysis.
The volume fraction was obtained directly by propor-
tional representation of the area of the histological
elements of the liver (hepatocytes, fibrosis, biliary ducts,
and other histological elements). The absolute fractions
of the mass of these components were obtained by
multiplying the volume fraction by the total mass of the
liver expressed in g/kg of corporal weight [6].
The morphometric analysis of the HSC was performed in
a similar manner using the same equipment described
above. Using the optical framer, 30 fields were randomly
selected from each slide with a  400 magnification. The
areas for HSC counting in the hepatic metabolic zone
1 were selected interactively and independently using
the KS 400 software (Kontron Elektronik GmbH). The
results were obtained as the sum of the number of HSC
in each of the 30 fields obtained from each slide.
Mitochondrial function analysis
Isolation of the hepatic mitochondria
To study mitochondrial function, part of the right hepatic
lobe was removed and placed in a physiologic solution at
4˜1C, fragmented with straight scissors, and conditioned in
a polystyrene box containing crushed ice. The hepatic
fragments were placed in a homogenized medium of
250mmol/l sucrose, 1mmol/l EGTA, and 10mmol/l
HEPES–KOH (pH 7.2). The liver tissues were homo-
genized in a Potter–Elvehjem for three cycles of 3 s each,
with an interval of 1min between the cycles. The
mitochondria were isolated using differential centrifuga-
tion [20]. The resulting homogenate was centrifuged at
770g for 5min to separate the cellular debris, the nuclei,
and any intact cells. The resulting supernatant was then
centrifuged at 9800g for 10min. The resulting sediment
containing the mitochondrial fraction was suspended in
10ml of 250mmol/l sucrose, 0.3mmol/l EGTA, and
10mmol/l HEPES–KOH (pH 7.2), followed by a 15-min
centrifugation at 4500g. The final sediment was sus-
pended in a solution containing 250mmol/l sucrose and
10mmol/l HEPES–KOH (pH 7.2). All procedures were
performed at 41C and within a 2-h period.
Determination of mitochondrial protein
Mitochondrial protein was determined using the Biuret
method modified by the addition of 1% cholate [21].
Mitochondrial respiration study
The oxidative and phosphorylated mitochondrial activ-
ities were determined polarographically at 301C using an
oxygraph (Physics Institute of Sa˜o Carlos – USP)
equipped with a Clarck electrode [22]. In these assays,
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2.6mg of mitochondrial protein was energized with
5mmol/l succinate/4 mmol/l rotenone in a respiration
environment containing 250mmol/l sucrose, 65mmol/l
KCl, 1mmol/l MgCl2, 2mmol/l KH2PO4, 0.1mmol/l
EGTA, and 10mmol/l HEPES–KOH (pH 7.4) in a final
volume of 2.6ml.
The rate of oxygen consumption after the addition of
200 nmol/l ADP to the energized mitochondria with
succinate (state III) and after ADP phosphorylation
(state IV) was expressed in atoms of oxygen/minute/
protein. The respiratory control ratio (RCR) was deter-
mined from the ratio between state III and IV. The
adenosine diphosphate/oxygen (ADP/O) ratio was deter-
mined by the division of the added ADP by the oxygen
consumed during the phosphorylation of all the added
ADP.
Mitochondrial phosphorylation activity was calculated by
multiplying the state III respiration by the ADP/O ratio.
Determination of the mitochondrial membrane potential
The mitochondrial membrane potential was determined
using an SLM Aminco spectrofluorometer (SLM –
Aminco, Rochester, New York, USA) with safranin, using
495 and 586nm for the excitation and emission wave-
lengths, respectively. In these assays, 1mg of mitochon-
drial protein was energized with 5mmol/l succinate/
4mmol/l rotenon in an environment of 200mmol/l sucrose,
1mmol/l MgCl2, 0.03mmol/l EGTA, and 20mmol/l
HEPES–KOH (pH 7.4) [23].
Statistical analysis
In the cases in which it was necessary to consider the
dependence among multiple variables, analysis was
performed using mixed-effects models. An analysis of
variance was applied when the groups were independent.
A significance threshold level of 5% was used. The PROC
MIXED procedure of the SAS version 9 software (SAS
Institute Inc., Cary, North Carolina, USA) was used for
statistical analysis [24]. When a significant difference was
found using ANOVA, Tukey’s post-hoc test was
applied [25]. The PROC GLM procedure of the SAS
9.0 software [26] was used in this analysis. In some cases,
logarithmic transformations were applied to assess the
residual of the models.
Results
Evaluation after the induction of cholestasis and biliary
anastomosis
A total of 158 animals were subjected to BO. One
hundred and seven animals (67.72%) developed signs of
cholestasis (jaundice, choluria, or a visible or a palpable
biliary duct dilation), 32 animals (20.25%) died, and 19
animals (12.02%) did not develop any signs of cholestasis.
The mortality rate was 76.19% for the CD group and
83.05% for the CJ group. The vast majority of postsurgery
deaths, 48 animals (59.2%), occurred within the first 72 h
after surgery. There were no deaths among animals of the
SO group.
Upon macroscopic examination, the liver had a hard
consistency and was yellow in color. The spleen was also
enlarged (Fig. 2). The bilioenteric anastomoses were
wide and patent, with a diameter of B0.5 cm in all
animals (Fig. 3). However, enteric contents and fur
occupying the anastomoses, the biliary duct, and the CJ
afferent loop were present in animals that underwent
both the biliary anastomosis techniques (Fig. 4).
Biochemical analysis of the blood
When compared with the SO group, animals who had BO
showed a significant increase in TB, bilirubin fractions,
aminotransferase, and ALP. After CD and CJ, there was a
significant reduction in the amount of TB, bilirubin
fractions, aspartate aminotransferase, and ALP. A sig-
nificant reduction in ALT occurred only after CJ. The
ALP, TB, and indirect bilirubin values were significantly
higher in the CD group than in the SO group (Table 1).
There was a significant reduction in the amount of serum
ALB after BO. CD led to a significant reduction in
serum ALB, whereas CJ did not alter the ALB levels
(Table 1).
Microbiological analysis of bile
No bacterial growth was detected in the bile samples
from the animals in the SO and the BO groups. However,
of the 20 animals subjected to either CD or CJ, 16 of the
animals had bacteria in their bile. Of these 16 animals, 10
were from the CD group. Escherichia coli were the most
common bacteria isolated from these animals and were
present in 10 animals (Fig. 5).
Histological analysis of the liver
Qualitative microscopic analysis
In all animals subjected to BO, an intense proliferation
of the biliary ducts and fibrosis were observed. Alterations
in the liver were more evident in the portal spaces.
However, there was irradiation with variable intensity
within the hepatic lobule, in the direction of the central
vein. This process produced septation of the hepatic
parenchyma with the formation of hepatocyte islands,
called parenchymatous nodules. Lymphomononuclear
inflammation was intermingled within the fibrosis and
biliary ducts. Infiltration of neutrophils and plasmocytes
was mild in zones 2 and 3 of the hepatic lobule and
moderate in zone 1 of the hepatic lobule.
After biliodigestive anastomosis, there was restoration of
the hepatic architecture, with a reduction in ductal
proliferation and parenchymatous nodules. The reduction
in fibrosis was more discrete, with the persistence of the
septum in the portal spaces (Fig. 6). Lymphomono-
nuclear inflammation was observed after anastomosis.
Neutrophil and plasmocyte infiltration was mild in zones
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2 and 3 of the hepatic lobule and moderate in intensity in
zone 1 of the hepatic lobule.
The number of HSC was not altered in the BO group
compared with the SO group. After biliary anastomosis,
the number of HSC increased. This increase in the
number of HSC was more noticeable in the animals that
underwent CD (Fig. 6).
Analysis of the estimated liver mass and quantitative
microscopic analysis of histological components
When compared with animals in the SO group, animals in
the BO group showed a significant increase in the
estimated hepatic mass. After CD and CJ, the estimated
mass of the liver was significantly reduced compared with
the BO group. The CD and CJ groups had estimated
mass values that were equivalent to the SO group.
However, the hepatocyte mass was not altered in the BO
group or after biliodigestive anastomoses (Table 2).
The BO group showed a significant increase in the
relative fibrotic mass and an increase in the mass of
the bile ducts compared with the SO group. After
biliodigestive anastomoses, there was a significant reduc-
tion in the estimated mass of fibrosis compared with the
BO group. However, after CD or CJ, there was no
reduction in the mass of the bile ducts. The fibrotic mass
and biliary duct mass of the CD and CJ groups remained
significantly higher compared with the values of the SO
group (Table 2).
In terms of the relative mass of other histological
elements, there was a significant increase in the BO
group compared with the SO group. After biliodigestive
anastomoses, there was a significant reduction in the
other histological elements compared with the BO group.
However, there were no differences in the other
histological elements in the CD and CJ groups compared
with the SO group (Table 2).
Compared with the SO group, the increase in the number
of HSC observed in the BO group was not significantly
different. A significant increase in the number of HSC
was observed in the CD group compared with the BO
group. After CD and CJ, the number of HSC remained
significantly higher than that of the SO group (Table 2).
Fig. 2
Schematic representation of the biliary obstruction technique through ligation, followed by circling the biliary duct (a), with fibrosis and a ductal
dilation zone (b). In the lower panel (from left to right), the rat liver (top) and spleen (bottom) subjected to the sham surgery can be seen (c) 2 weeks
after biliary obstruction, where there is a pronounced hepato-splenomegaly (d), and 4 weeks after biliary obstruction (e). A discrete retraction of the
liver is observed after 4 weeks, whereas the spleen is enlarged. These data suggest the progression of hepatic lesions (e).
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Analysis of the estimated mass of the spleen
After BO, the relative mass of the spleen was significantly
increased compared with that of the SO group. After
biliodigestive anastomosis, a significant reduction in the
estimated mass of the spleen was observed compared
with the BO group. However, CJ induced a more
significant reduction in the splenomegaly (Table 2).
Biochemical analysis of liver tissue
Mitochondrial function
After BO, oxygen consumption during state 3 mitochon-
drial respiration was reduced. However, the difference
was not significant compared with the SO group. After
CD or CJ, there was a significant increase in oxygen
consumption during state 3 compared with the BO group.
In terms of oxygen consumption during state 4 mitochon-
drial respiration, there was a significant increase in the
BO group compared with the SO group, which after CD
and CJ reverted to the same level as the SO group.
Oxygen consumption after CJ was significantly lower than
that after CD. However, oxygen consumption remained
significantly higher in both the CD and the CJ groups
compared with the SO group (Table 3).
The RCR and the ADP/O ratio were significantly reduced
in the BO group compared with the SO group. After
either CD or CJ, there was a significant increase in the
ADP/O ratio. A significant increase in the RCR was found
only in the CJ group. A recovery in the RCR and ADP/O
ratio was not observed in the CD group compared with
the SO group (Table 3). Furthermore, the mitochondrial
membrane potential was not altered in the presence of
BO or after biliodigestive anastomoses (Table 3).
The oxidative phosphorylation index was significantly
reduced in the BO group compared with the SO group. In
the CD and CJ groups, the level of oxidative phosphor-
ylation reached a level similar to that of the SO group
(Table 3).
Discussion
Quantitative and qualitative anatomopathological lesions,
excretory function, and energy metabolism of the liver
have been widely studied in models of experimental
chronic extrahepatic cholestasis [7,27–29]. However, few
reports have evaluated the effects of biliodigestive
anastomosis on the regression of the hepatic lesions in
these models of chronic extrahepatic BO [6,7,10,30].
Studies comparing these conditions in the long term,
evaluation of CD and CJ performance, and the possible
effects of these treatments on the liver and the biliary
ducts are rare [8]. The use of CD because of the
anatomical, functional, and technical advantages (espe-
cially in the video-laparoscopy era) and the possibility of
a hepatic transplant for the treatment of secondary biliary
cirrhosis with portal hypertension justify this study.
Fig. 3
Dilated hepatic duct in a rat after 4 weeks of biliary obstruction (arrow) and liver with a granular surface (a). (b) Duodenum and the biliary duct with
interior mucus can be observed as open and overlapped for the performance of the anastomosis.
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In the present study, chronic BO was induced through
ligation and circling of the extrahepatic biliary duct for 4
weeks [8]. Animals subjected to BO in this study lost
their hepatic architecture because of duct proliferation
and hepatocyte island formation induced by fibrous septa
that established bridges between the portal spaces and
Fig. 4
A, A1 and A2 – The necropsy product of an animal subjected to CD with en-bloc extraction of the esophagus, stomach, duodenum, and biliary duct
(a). The biliary duct had an organized mass containing hair and food, similar to a calculus with a consistency of clay (A1), although the anastomosis
was wide and patent (A2). B, B1 and B2 – The necropsy product of an animal subjected to CJ with an excluded loop of 15 cm. There is a bulging of
the CJ and the jejunum–jejunal anastomotic confluence (b). Detail of the jejunum–jejunal confluence with food stasis (B1), and the presence of a CJ
with an organized mass containing hair and food, similar to a calculus of clay-like consistency (B2). CD, choledochoduodenostomy; CJ,
choledochojejunostomy.
Table 1 Biliary obstruction effect (BO, BO1, and BO2) and the effect of choledochoduodenostomy and choledochojejunostomy on
canalicular and cellular enzymes and albumin, expressed in terms of mean±SD
SO (n=8) BO (n=6) BO1 (n=10) CD (n=10) BO2 (n=10) CJ (n=10)
TB 0.28±0.09 8.45±1.01 9.35±1.40 0.40±0.10 9.58±2.34 0.32±0.09 *1
DB 0.09±0.05 6.32±0.62 6.07±1.08 0.08±0,05 6.63±1.62 0.08±0.02 *2
IB 0.023±0.21 2.05±0.48 3.28±1.22 0.33±0.07 2.95±1.13 0.24±0.07 *1
ALT 95.25±34.67 234.83±103.87 209.70±55.27 195.60±259.96 188.90±74.01 101.70±31.87 *3
AST 194.13±70.77 493.58±131.12 473.00±110.32 326.60±291.94 455.20±215.81 194.40±50.49 *2
ALP 80.88±21.07 369.83±86.31 450.70±66.47 154.10±51.81 415.60±110.92 84.80±23.37 *4
ALB 2.41±0.13 1.87±0.27 2.29±0.37 1.90±0.50 2.29±0.27 2.28±0.13 *5
ALB, albumin; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BO, biliary obstruction; CD, choledochoduodenostomy;
CJ, choledochojejunostomy; DB, direct bilirubin; IB, indirect bilirubin; TB, total bilirubin.
*1 – Multiple significant comparisons: SO versus BO, BO1, and BO2; BO1 versus CD; BO2 versus CJ; and SO versus CD.
*2 – Multiple significant comparisons: SO versus BO, BO1, and BO2; BO1 versus CD; and BO2 versus CJ.
*3 – Multiple significant comparisons: SO versus BO, BO1, and BO2 and BO2 versus CJ.
*4 – Multiple significant comparisons: SO versus BO, BO1, and BO2; BO1 versus CD; BO2 versus CJ; CD versus CJ; and SO versus CD.
*5 – Multiple significant comparisons: SO versus BO; BO versus BO1 and BO2; BO1 versus CD; CD versus CJ; and SO versus CD.
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fragmented the hepatic parenchyma. This histological
pattern is referred to as secondary biliary cirrho-
sis [6,28,30–33]. From functional and metabolic view-
points, there were signs of cell damage, which translated
into hypoalbuminemia, decoupling of the electron
transportation chain in accordance to the reduction of
the mitochondrial RCR, and a reduction in the oxidative
phosphorylation index.
In the present study, the postsurgery mortality was high
(CD: 76.19% and CJ: 83.05%). The animals that died
after a bile shunt were subjected to autopsies, which
did not indicate any mechanical or infectious causes,
dehiscence of the anastomoses, or abdominal bleeding
that would justify death. On the basis of this information
and on the data of other studies, we deduce that the high
mortality rate found in the present study might have
been related to the different degrees of the hepato-
cellular lesion resulting from the BO [34,35], metabolic,
anesthetic, and hemodynamic effects [6,36] and the
hepatic injury of ischemia and reperfusion [37,38].
In the present study, food that refluxed from the
intestine to the biliary duct was observed in the biliary
channels and in the anastomoses. The food was organized
as friable calculus in both types of biliary anastomoses
that were used in this study. The excluded loop of the
Roux-en-Y, despite having 15 cm of extension (propor-
tionally corresponding to 40 cm in humans), was not
enough to avoid the reflux and the stasis. These findings
may be the cause of the transitory episodes of cholestasis
and cholangitis described previously in humans [39] and
experimental models [10,11], which contradicts the
common belief that a wide and pervious anastomosis is
enough to ensure the resolution of BO without additional
problems [6,40,41].
The findings presented here reinforce the hypothesis
that the biliary duct acts as a passive structure in the
biliodigestive anastomosis [42]. After biliary anastomosis,
there is a reduction in the biliary duct pressure resulting
from the functional elimination of the sphincter mechan-
ism. The propulsive power of the duodenal wall adds to
the biliary duct pressure, leading to duodeno-biliary
reflux. However, the sectioned jejunal loop for the
Roux-en-Y ceases to receive the duodenal pacemaker
and the continuity of phase III of contraction [43]. A new
pacemaker could develop in the middle of the excluded
loop, but at a low frequency of contraction and possibly in
a retrograde direction [44].
Free circulation of the enteric content to the biliary duct
may induce transitory episodes of mechanical obstruction.
These mechanisms can justify the persistence of an
increase in ALP and ALT in the animals subjected to CD,
as well as the presence of food in the biliary duct in
almost all of the treated animals. These mechanisms may
also explain the transitory episodes of cholangitis that are
present in humans without signs of mechanical obstruc-
tion [12,39,45,46].
In the present study, animals with a BO had a discrete
mononuclear inflammatory infiltrate in the portal spaces
and no bacterial contamination of the bile. In addition to
the contamination of the bile with multiple gram-
negative bacteria (normally found in biliary infections),
a mixed inflammatory infiltrate of variable intensity was
found in the animals treated with biliary anastomosis.
These findings reinforce the possibility of ascending
contamination of the biliary duct as a cause of cholangitis
after biliary anastomosis [47–50]. These alterations can
explain the increase in ALP, hypoalbuminemia, and ALT,
in addition to explaining the increased number of stellate
Fig. 5
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cells (especially in animals in which CD was performed
and reflux may have been more intense).
Both anastomotic techniques provided the re-establish-
ment of biliary flow and a regression in the hepatic-
splenomegaly and the fibrotic mass. However, rats
exposed to 3 or 4 weeks of BO and treated with CD or
CJ showed a regression in the fibrosis, but not a
correction of the portal hypertension [6,10,30]. The
reason for the delay in the repair of the portal pressure,
despite fibrosis regression, is not clear. This delay in
recovery has been attributed to the proliferation of HSC
that seems to be more strongly correlated with portal
hypertension than with fibrosis itself [30].
In the present study, even after the resolution of BO,
there was a significant increase in the number of HSC
after CD. However, there was no change in the number of
HSC after CJ. The lack of normalization of the number of
HSC and portal hypertension suggests that the adverse
effects of the biliary anastomoses, such as enterobiliary
reflux and bacterial contamination of the bile ducts, not
only aggravate the inflammatory process (especially in
zone 1 of the hepatic lobules), but maintain the
Fig. 6
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stimulation of HSC proliferation [30]. Moreover, these
findings reinforce the possibility that HSC themselves
alter the sinusoidal space through the contraction of their
dendritic spines and therefore maintain portal hyperten-
sion [51–53]. In the present study, despite the regression
of fibrosis, splenomegaly remained unaltered after CD.
However, the splenic mass regressed, but without
complete recovery after CJ. These data reinforce the
association between HSC mass and portal hyperten-
sion [30].
The majority of the cholestatic and metabolic alterations,
in addition to the anatomopathological lesions in the liver,
reversed after efficient biliary anastomosis. However,
bilioenteric reflux leads to intraductal and intracanalicular
obstruction with cholestasis and a transitory increase in
the pressure within the biliary duct, with no changes
in ductal proliferation. The presence of enteric contents
in the anastomoses and biliary ducts of all the animals
(especially in those treated with CD) reinforces the
notion that the communication between the biliary duct
and the intestine, even in the presence of a wide and
pervious anastomosis, does not ensure normal biliary flow.
The results of the present work reinforce the concept of
reversibility of cholestatic and metabolic alterations after
the relief from cholestasis. These alterations can be
reversed even in advanced lesions with fibrosis and in
secondary biliary cirrhosis. These observations are in
agreement with the concept developed from clinical [4]
and experimental [5–7,34] observations. These data
indicate that, whenever possible, effective biliary des-
obstruction should precede hepatic transplant in patients
with a treatable secondary biliary cirrhosis and portal
hypertension through biliodigestive anastomosis.
The novel contribution of this work validates the
advantages of CJ and supports the need for clinical
studies and the acquisition of more information on the
selection of the type of biliary anastomosis used for
treatment. Although the enterobiliary reflux is present in
the two types of anastomosis, the quantity of food and the
organization of the refluxed material in the biliary duct
after CD were larger. In addition, the incidence of biliary
contamination was higher after CD. The data suggest the
probability of easy access of the enteric contents derived
from the duodenum into the biliary duct that allows
transitory closure, which increases the intrabiliary pres-
sure. This phenomenon could be sufficient to maintain
the TB and ALP at a higher level. The perpetuation of
cholestasis delays the repair of histological lesions and the
Table 2 Effect of biliary obstruction and choledochoduodenostomy and choledochojejunostomy on the relative mass of the liver and
spleen (g/kg), liver histological components (g/kg), and the number of hepatic stellate cells (mean±SD)
SO (n=8) BO (n=6) CD (n=10) CJ (n=10)
Hepatic mass 33.72±3.37 60.71±6.38 35.13±6.75 35.78±3.35 *1
Splenic mass 1.74±0.13 6.81±1.39 4.23±1.53 3.08±0.57 *2
Hepatocytes 22.71±3.19 23.19±6.22 21.07±5.49 22.74±2.42 NS
Fibrosis 0.07±0.05 6.64±2.19 1.29±0.56 0.84±0.31 *3
Biliary ducts 0.02±0.02 6.24±1.77 0.65±0.43 0.41±0.33 *4
Other components 10.61±1.96 23.37±3.15 12.12±2.42 11.90±2.42 *1
Stellate cells 24.13±12.86 38.67±13.06 71.50±32.68 56.00±21.97 *5
BO, biliary obstruction; CD, choledochoduodenostomy; CJ, choledochojejunostomy; SO, sham operation.
*1 – Multiple significant comparisons: SO versus BO and BO versus CD and CJ.
*2 – Multiple significant comparisons: SO versus BO; BO versus CD and CJ; CD versus CJ; and SO versus CD and CJ.
*3 – Multiple significant comparisons: SO versus BO; BO versus CD and CJ; and SO versus CD and CJ.
*4 – Multiple significant comparisons: SO versus BO and SO versus CD and CJ.
*5 – Multiple significant comparisons: BO versus CD; and SO versus CD and CJ.
Table 3 Biliary obstruction effects and the effect of choledochoduodenostomy and choledochojejunostomy on liver oxidative
phosphorylation (mean±SD)
SO (n=8) BO (n=6) CD (n=10) CJ (n=10)
State 3 89.26±18.07 70.61±8.03 107.97±21.07 107.89±23.23 *1
State 4 22.77±5.53 44.43±5.33 47.75±12.21 35.40±9.14 *2
ADP/O 1.54±0.11 0.78±0.09 1.24±0.40 1.35±0.26 *3
RCR 4.10±1.21 1.58±0.20 2.23±0.63 3.14±0.67 *4
Membrane potential 149.50±2.50 150±0 149.6±0.84 148.60±0.96 NS
Oxidative phosphorylation index 136.89±28.36 55.42±10.51 133.71±45.35 144.24±38.39 *5
ADP/O, adenosine diphosphate/oxygen; BO, biliary obstruction; CD, choledochoduodenostomy; CJ, choledochojejunostomy; RCR, respiratory control ratio;
SO, sham operation.
*1 – Multiple significant comparisons: BO versus CD and CJ.
*2 – Multiple significant comparisons: SO versus BO; CD versus CJ; and SO versus CD and CJ.
*3 – Multiple significant comparisons: SO versus BO; BO versus CD and CJ; and SO versus CD.
*4 – Multiple significant comparisons: SO versus BO; BO versus CJ; CD versus CJ; and SO versus CD.
*5 – Multiple significant comparisons: SO versus BO; and BO versus CD and CJ.
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metabolic recovery of the mitochondria. The presence of
biliary duct contamination and the resulting inflammation
may contribute to the increased number of HSC and
consequently to a less significant regression of the
splenomegaly, especially after CD.
Conclusion
Biliary interventions should minimize the intensity of the
effects resulting from enterobiliary reflux and biliary duct
stasis. The effects of biliary interventions justify the
evaluation of new technical and therapeutic techniques
for benign diseases related to extrahepatic cholestasis, as
suggested previously. Moreover, even with concerns
regarding the generalization of these experimental results
to humans, caution should be exercised in the frequent
use of CD. The choice of a biliary intervention should be
made carefully, especially in the video-laparoscopic era,
for cases of chronic BO with a good prognosis.
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